Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

ErGe BioTech AB

Closing information (x1000 SEK)

Closing information 2024/04 2023/04 2022/04
Turnover 1,317 More Arrow 1,427 Less Arrow 1,308
Financial expenses 0 More Arrow 1 Equal arrow 1
Earnings before taxes 261 More Arrow 506 Less Arrow 456
EBITDA 260 More Arrow 507 Less Arrow 457
Total assets 2,004 Less Arrow 1,832 Less Arrow 1,495
Current assets 977 Less Arrow 805 Less Arrow 468
Current liabilities 53 More Arrow 166 More Arrow 229
Equity capital 1,854 Less Arrow 1,541 Less Arrow 1,146
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 1 Equal arrow 1 More Arrow 2

Financial ratios

Fiscal year 2024/04 2023/04 2022/04
Solvency 92.5% Less Arrow 84.1% Less Arrow 76.7%
Turnover per employee 1,317 More Arrow 1,427 Less Arrow 654
Profit as a percentage of turnover 19.8% More Arrow 35.5% Less Arrow 34.9%
Return on assets (ROA) 13.0% More Arrow 27.7% More Arrow 30.6%
Current ratio 1843.4% Less Arrow 484.9% Less Arrow 204.4%
Return on equity (ROE) 14.1% More Arrow 32.8% More Arrow 39.8%
Change turnover -110 More Arrow 119 Less Arrow -44
Change turnover % -8% More Arrow 9% Less Arrow -3%
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -50% More Arrow 0%

Total value of public sale

Fiscal year 2024/04 2023/04 2022/04
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.